Amber Harezlak, Ph.D. Profile, Deals & Rankings

Amber Harezlak's representative experience includes advising:

Life Sciences & Healthcare

Blackstone and TPG in the pending $18.3 billion acquisition of Hologic, a provider of medical device and diagnostic products
Akero Therapeutics in its pending $5.2 billion sale to Novo Nordisk
Eli Lilly in its $1.925 billion acquisition of Versanis Bio and in its agreement with OpenAI to develop new antimicrobial treatments
Bristol Myers Squibb in its $4.1 billion acquisition of Turning Point Therapeutics and $5.8 billion acquisition of Mirati Therapeutics
Patient Square Capital in its $7.1 billion acquisition of Syneos Health
Slayback Pharma in its sale to Azurity Pharmaceuticals

Software, AI & Services

Gryphon Investors in its pending sale of 3Cloud to Cognizant and investment in phData
Thoma Bravo-backed Sophos on its $2 billion acquisition of QAD Inc.
Blackstone-backed Irth Solutions in its sale to TPG
Francisco Partners in the acquisition of Litmos from SAP SE
HGGC in its $115 million investment in Upland Software

Business Services

Alpine Investors in its acquisition of Cirrus Asset Management through Oakline Properties
HGGC in its acquisition of Equity Methods
TPG Rise Climate in its acquisition of Olympus Terminals

Consumer Products, Services & Brands

GIC-backed CitizenM on the sale of the “citizenM” boutique hotel brand to Marriott International
Kimberly-Clark Corp. in its $3.4 billion strategic partnership with Suzano
Gryphon Investors in its acquisition of Spindrift Beverage Co.
Oak View Group in the acquisition of Spectrum Catering, Concessions & Event Services

Materials & Manufacturing

I Squared Capital in its acquisition of Liberty Tire Recycling
SCF Partners in its $285 million acquisition of the Pipeline and Industrial Materials business from Entegris
Gryphon Investors-backed Techmer PM in its acquisition of Colors for Plastics

Amber Harezlak, Ph.D.